To investigate ACE-I, ARB and type 5 PDE-I drugs in the context of ARDS and microvascular dysfunction in Covid-19 patients.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Arthur WallaceResearch Location
United States of AmericaLead Research Institution
University of California-San Francisco, San Francisco VA Medical CenterResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
N/ASpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified